News

BFET

IPO report: OncoMed Pharmaceuticals

Francis Gaskins | Equities.com |

Summary OMED targets cancer stem cells (CSC), which is different from conventional chemotherapies and targeted therapies. By targeting cancer stem cells OMED hopes to prove in can put the cancer



Discover: Trending Events

United Nations
EU Parliament
Humanity 2.0
World Economic Forum